At the intersection of oncology and digital health, one product strategist stands out for her impact on how doctors access critical cancer testing data. Vaidehi Mahajan, senior product manager at Natera, has elevated the provider experience through her work on a platform that gives real-time access to patient-specific molecular testing information.
Reimagining Cancer Care Technology
The Signatera Provider Portal represents the next step in how healthcare professionals interact with complex cancer testing data. Under Vaidehi's leadership, the platform now offers streamlined access to critical patient information, allowing doctors to check test results and manage orders through a single interface.
It is not uncommon for those of the medical trade to struggle with disjointed healthcare systems and test result delays due to technological limitations. Vaidehi's work sought to correct this experience by creating a system that puts holistic patient data at physicians' fingertips, enabling faster clinical decisions and more efficient patient care.
Building Bridges Between Data and Treatment
Drawing on her extensive experience in healthcare technology, including roles at Inovalon, Vaidehi Mahajan has dedicated her career to solving critical challenges in oncology. Her work addresses a pressing need: connecting doctors with time-sensitive molecular testing data that can directly influence patient outcomes.
During her tenure at Inovalon, Vaidehi Mahajan played a key role in the development of eCAAS Advantage®, a cloud-based platform that revolutionized how health plans manage and submit electronic claims data under the Affordable Care Act. The platform's success significantly improved data integrity, ultimately supporting better health outcomes for millions of patients. This experience in designing large-scale healthcare data systems and navigating the intricacies of healthcare data privacy and security regulations proved invaluable as she transitioned to addressing real-life challenges in cancer care, particularly the complexities of molecular testing.
"To improve cancer care, we need to focus on giving healthcare providers immediate access to the information they need, when they need it," said Vaidehi. Her efforts have significantly accelerated doctors' access to and interpretation of complex molecular testing results, enabling faster and more informed treatment decisions for cancer patients.
The platform's success is partially credited to Vaidehi Mahajan's unique blend of technical expertise and understanding of clinical workflows. Her experience in developing healthcare interoperability standards at Valant combined with her work on customer facing solutions at Inovalon allowed her to create a system that balances sophisticated functionality with user friendly design. By bridging the gap between data and treatment, Vaidehi Mahajan's work continues to shape the future of oncology care.
Impact on Patient Outcomes
Research shows that healthcare portals in cancer care settings have achieved adoption rates as high as 42.4%, significantly higher than other medical specialties. This increased engagement directly translates to better patient care and more informed treatment decisions.
The platform's success has caused many industry fixtures to reconsider their use of digital tools in oncology. Under Vaidehi's guidance, the portal has become an essential resource for healthcare providers, supporting everything from initial diagnosis through treatment monitoring and survivorship care.
"Every minute saved in accessing test results is a minute gained in patient care," Vaidehi emphasized while discussing advancements in healthcare technology. "We wanted to create a system that removes technical limits so that doctors can focus on treating their patients instead of combing through multiple platforms."
Through her leadership, Vaidehi Mahajan works closely with clinicians to enhance the platform's capabilities. Her achievements show how thoughtful product development can turn medical care delivery on its head, making a tangible difference in the lives of cancer patients and their healthcare providers.
